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SResults: NSE levels signiﬁcantly increased after coronary angiography and inter-
vention compared to baseline levels (22.0327.70, 10.083.15 consecutively).
Baseline characteristics were similar between groups (Table-1). Left ventricular
ejection fraction in the SNI+ group was signiﬁcantly lower than SNI- group
(43.7112.51%, 50.849.34%, p¼0.002). Maximal CK-MB, Troponin-I, Syntax
Score (SS), of SNI+ group were signiﬁcantly higher than SNI- group (103.8399.22,
51.9278.33, p¼0.006; 50.0466.18, 19.1830.50, p¼0.002; 103.8399.22,
51.9278.33, p¼0.006 and 50.0466.18, 19.1830.50, p¼0.002 successively). SS
and performing PCI were the independent predictors of SNI (p¼0.009, OR¼1.06,
95%CI¼1.014-1.107, p¼0.036, OR¼4.262, 95%CI¼1.097-16.56).
Conclusions: PCI and coronary artery lesion complexity may increase the risk of SNI
in patients with acute coronary syndrome.Table-1
Variable SNI+ SNI- p value
Age, year 62.689.33 64.0111.27 0.566
Male n(%) 26 (83.8%) 49 (73.1%) 0.243
Body Mass Index, kg/m2 28.064.03 28.014.85 0.515
Hypertension, n(%) 10 (32.3%) 25 (37.3%) 0.627
Diabetes, n(%) 10 (32.3%) 24 (35.8) 0.730
Hyperlipidemia, n(%) 9 (28.1%) 22 (32.8%) 0.782
Smoking, n(%) 11 (35.5%) 20 (29.9%9 0.752
Atrial ﬁbrillation, n(%) 2 (6.5%) 8 (11.9%) 0.404
Mean Arterial Pressure, mmHg 100.7113.80 98.2612.14 0.374
Percutaneous Coronary
Intervention, n(%)
21 (67.7%) 30 (44.8%) 0.034
SYNTAX score 28.1314.68 18.7113.23 0.002
Fluoroscopy Time, min 6.374.23 4.704.16 0.069
estimated Creatinine Clearance,
ml/min
103.6530.51 99.1034.47 0.530
Glucose, mg/dl 127.7160.40 133.0767.80 0.707
LDL, mg/dl 141.3242.59 135.1947.74 0.733
Total Cholesterol, mg/dl 201.2166.84 205.8555.17 0.718
Hemoglobin, g/dl 14.421.59 13.971.70 0.210
Mean Platelet Volume, femtolitre 8.271.51 8.210.93 0.797
Red cell Distribution Width, % 13.550.91 13.361.42 0.498
CK-MB, ng/ml 103.8399.22 51.9278.33 0.006
Troponin-I, ng/ml 50.0466.18 19.1830.50 0.002
Left Atrial diameter, mm 38.294.09 38.515.85 0.853
Left Ventricular End Diastolic
Diameter, mm
49.905.83 49.305.03 0.600
Left ventricular End Systolic
Diameter, mm
36.105.76 33.396.00 0.037
Ejection Fraction, % 43.7112.51 50.849.34 0.002
Asendan Aorta diameter, mm 34.714.11 34.574.20 0.875OP-012
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Objective: We prospectively assessed the management and short term prognosis of
no-reﬂow phenomenon in a tertiary referral hospital.
Methods: We included 46 patients with ST-segment elevation acute myocardial
infarction (STEMI) and occurrence of no-reﬂow phenomenon after primary percuta-
neous coronary intervention. They were all received intravenous tiroﬁban and then
randomized into one of the 3 groups: intracoronary adenosine (n¼16), intracoronary
verapamil (n¼15) or serum physiologic as placebo (n¼15). Intracoronary drugs were
administered after stent implantation. Thrombolysis In Myocardial Infarction (TIMI)
frame counts were used to assess coronary ﬂow.
Results: Groups were similar in terms of age, sex, STEMI localisation, diabetes,
hypertension, mean reperfusion time. Hemotologic and biochemical blood param-
eters and procedural properties were also similar between groups (stent size andC4 JACC Vlength, diameter and number of balloon(s) and stent(s) used). Verapamil plus tir-
oﬁban therapy had signiﬁcant effect in restoring impaired coronary blood ﬂow,
decreasing TIMI frame count from 7344 to 5248 (p¼0.024). However, adeno-
sine and serum physiologic administration were not found to be so effective in
decreasing TIMI frame count (from 8135 to 7146, p¼ 0.084; from 7432 to
7137, p¼0.612; respectively). In-hospital and 6-month survival rates were similar
among groups.
Conclusion: Tiroﬁban plus verapamil restored the impaired coronary blood ﬂow more
effectively than tiroﬁban plus adenosine and tiroﬁban only. Although both verapamil
and adenosine have multiple effects on coronary circulation and even on platelet
aggregation, verapamil as a calcium channel blocker, not only relieves microvascular
spasm but also reduces calcium inﬂux into ischemic cells, relieves cellular edema and
restores calcium homeostasis. It may be hypothesized that these additional features put
verapamil ahead of other drugs and may explain the better results we obtained with
verapamil in comparison to adenosine.
OP-013
A Simple Index to Predict Adverse Clinical Outcome Associated with Acute
Myocardial Infarction in Primary PCI Era
Mustafa Tarık Agaç1, Suret Agaç4, Levent Korkmaz1, Turhan Turan2,
Hüseyin Bektas¸1, Ali Rıza Akyüz2, Mustafa Çetin1, Hakan Erkan1, Bülent Vatan3,
S¸ükrü Çelik1
1Ahi Evren Cardiovascular and Thoracic Surgery Training and Research Hospital,
Department of Cardiology, Trabzon, 2Akcaabat Hackali Baba State Hospital,
Department of Cardiology, Trabzon, 3Sakarya University Medical Faculty Hospital,
Department of Cardiology, Sakarya, 4Karadeniz Technical University Medical
Faculty Hospital, Department of Biochemisty, Trabzon
Background: The major determinant of ﬁnal infarct size for a given coronary
occlusion is the size of myocardium that the artery perfuses. Deﬁning the initial area-
at-risk (AAR) for infarction has major clinical implications since it permits an accurate
estimate of myocardial salvage provided by reperfusion therapies. We proposed a new
index 'Relative Importance Index (RII)' to predict potential infarct size in patients with
anterior MI.
Aim: The aim of the study is to assess the predictive role of RII for reduction in
systolic function and its relation to adverse clinical outcomes.
Methods: One Hundred twenty-three acute anterior MI patients with their ﬁrst acute
coronary syndrome incident were consecutively and prospectively enrolled to the
study. Patients with a clinical history of congestive heart failure, valvular heart
disease, and previous coronary revascularization were excluded. All patients under-
went primary percutaneous coronary intervention (PCI) for revascularization.
Angiographic exclusion criteria were 1) pre-procedural TIMI ﬂow 2 in the infarct
related artery, 2) chronic total occlusion of other arterial territory 3) any visible
collateral ﬂow to infarct related artery 4) diffuse disease at proximal segments of
coronary arteries that precludes deﬁning reference segment. Coronary diameters were
measured with quantitative coronary analysis program. RII was calculated by dividing
culprit segment diameter to the sum of diameters of LAD, Cx, and RCA at their
proximal segments (Figure 1). Troponin I (TnI) concentration at 72 hour was chosen
as a serological estimate of infarct size. We evaluated 1-month follow up rates of
major clinical endpoints (MCE), which is deﬁned as death, non fatal MI, stroke,
and new congestive heart failure. Left ventricular EF (LVEF) at 1st month was
chosen as an index for systolic function.
Results: RII was signiﬁcantly and negatively correlation LVEF (r¼-0.65, p<0.001)
(Figure 2). As RII of culprit lesion increased there was tendency to end up with lower
EF. Likewise, RII was signiﬁcantly correlated with 72 h TnI (r¼0.48, p<0.001).
Patients were dichotomized according to median value of RII (median RII¼0.30)
(Table 1). Supra-median RII was associated with lower EF and higher incidence of
composite MACE. The mortality (12.9% vs. 6.6%), non-fatal MI (6.5% vs. 3.3%),
and new CHF (12.9% vs. 3.3%) rate in supra-median RII group trend higher but
they did not reach statistical signiﬁcance. An RII >0.30 had a 88% sensitivity and
60% speciﬁcity (ROC area 0.82, p<0.001, CI [0.73-0.90]) for predicting severe LV
dysfunction (LVEF <30%) (Figure 3).
Conclusion: A Simple index derived from coronary angiography at time of primary
PCI can predict LV systolic function loss and adverse clinical outcome in patients with
acute anterior myocardial infarction.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
